{"title":"伦理、利润和病人:当制药公司赞助医学会议。","authors":"L. Barton","doi":"10.1300/J043v08n01_07","DOIUrl":null,"url":null,"abstract":"A series of dynamic changes underway in Washington could transform the manner in which physicians learn of new pharmaceutical therapies. The potential impact of these changes is likely to significantly affect the manner in which physicians learn about and prescribe medications for years to come; the ultimate effect on patient care has yet to be measured, however.","PeriodicalId":79671,"journal":{"name":"Journal of hospital marketing","volume":"8 1 1","pages":"71-82"},"PeriodicalIF":0.0000,"publicationDate":"1994-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1300/J043v08n01_07","citationCount":"2","resultStr":"{\"title\":\"Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.\",\"authors\":\"L. Barton\",\"doi\":\"10.1300/J043v08n01_07\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A series of dynamic changes underway in Washington could transform the manner in which physicians learn of new pharmaceutical therapies. The potential impact of these changes is likely to significantly affect the manner in which physicians learn about and prescribe medications for years to come; the ultimate effect on patient care has yet to be measured, however.\",\"PeriodicalId\":79671,\"journal\":{\"name\":\"Journal of hospital marketing\",\"volume\":\"8 1 1\",\"pages\":\"71-82\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1300/J043v08n01_07\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of hospital marketing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1300/J043v08n01_07\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hospital marketing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1300/J043v08n01_07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
A series of dynamic changes underway in Washington could transform the manner in which physicians learn of new pharmaceutical therapies. The potential impact of these changes is likely to significantly affect the manner in which physicians learn about and prescribe medications for years to come; the ultimate effect on patient care has yet to be measured, however.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
